Please login to the form below

Not currently logged in
Email:
Password:

Hansa Medical strengthens management team

Henk Doude van Troostwijk becomes vice president, commercial operations

Swedish biopharmaceutical company Hansa Medical has appointed Henk Doude van Toostwijk as its new vice president, commercial operations.

In his new role, van Troostwijk will be responsible for overseeing the firm's commercial assessments of its lead project IdeS, an orphan drug in development for organ rejection.

Goran Arvidson, president and chief executive of Hansa Medical, said: “We are very excited that Henk will engage in Hansa Medical, as we now start to prepare our commercialisation strategy for IdeS.”

Van Troostwijk brings over 20 years of sales and marketing experience in transplantation and orphan drugs, most recently as general manager of emerging markets at Raptor Pharmaceuticals.

He has also held a number of management positions at Bioenvisions, Bristol-Myers Squibb, Merck as well as serving as business unit director oncology and transplantation for Genzyme. 

27th May 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...